Cargando…
Association of the Somatostatin Analog Octreotide With Magnetic Nanoparticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic Retinopathy
The somatostatin analog octreotide (OCT) displays important neuroprotective and anti-angiogenic properties that could make it an interesting candidate to treat diabetic retinopathy (DR). Unfortunately, systemic drug administration is hindered by severe side effects, therefore topical administration...
Autores principales: | Amato, Rosario, Giannaccini, Martina, Dal Monte, Massimo, Cammalleri, Maurizio, Pini, Alessandro, Raffa, Vittoria, Lulli, Matteo, Casini, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051943/ https://www.ncbi.nlm.nih.gov/pubmed/32158755 http://dx.doi.org/10.3389/fbioe.2020.00144 |
Ejemplares similares
-
Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy
por: Amato, Rosario, et al.
Publicado: (2018) -
Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy
por: Rossino, Maria Grazia, et al.
Publicado: (2020) -
Lisosan G Protects the Retina from Neurovascular Damage in Experimental Diabetic Retinopathy
por: Amato, Rosario, et al.
Publicado: (2018) -
Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors
por: Filippi, Luca, et al.
Publicado: (2022) -
Diabetes Exacerbates the Intraocular Pressure-Independent Retinal Ganglion Cells Degeneration in the DBA/2J Model of Glaucoma
por: Amato, Rosario, et al.
Publicado: (2021)